Your browser doesn't support javascript.
loading
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Okosun, Jessica; Bödör, Csaba; Wang, Jun; Araf, Shamzah; Yang, Cheng-Yuan; Pan, Chenyi; Boller, Sören; Cittaro, Davide; Bozek, Monika; Iqbal, Sameena; Matthews, Janet; Wrench, David; Marzec, Jacek; Tawana, Kiran; Popov, Nikolay; O'Riain, Ciaran; O'Shea, Derville; Carlotti, Emanuela; Davies, Andrew; Lawrie, Charles H; Matolcsy, Andras; Calaminici, Maria; Norton, Andrew; Byers, Richard J; Mein, Charles; Stupka, Elia; Lister, T Andrew; Lenz, Georg; Montoto, Silvia; Gribben, John G; Fan, Yuhong; Grosschedl, Rudolf; Chelala, Claude; Fitzgibbon, Jude.
Affiliation
  • Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Bödör C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Wang J; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Araf S; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Yang CY; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Pan C; Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Boller S; School of Biology, Georgia Institute of Technology, Atlanta, USA.
  • Cittaro D; Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, USA.
  • Bozek M; Department of Cellular and Molecular Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  • Iqbal S; Centre for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milano, Italy.
  • Matthews J; Genome Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Wrench D; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Marzec J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Tawana K; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Popov N; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • O'Riain C; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • O'Shea D; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Carlotti E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Davies A; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Lawrie CH; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Matolcsy A; Cancer Sciences Division, University of Southampton, Southampton, United Kingdom.
  • Calaminici M; Oncology Department, Biodonostia Research Institute, San Sebastian, Spain.
  • Norton A; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Byers RJ; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Mein C; Department of Histopathology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Stupka E; Department of Histopathology, Manchester Royal Infirmary, Manchester, United Kingdom.
  • Lister TA; Genome Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom.
  • Lenz G; Centre for Translational Genomics and Bioinformatics, San Raffaele Scientific Institute, Milano, Italy.
  • Montoto S; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Gribben JG; Department of Hematology, Oncology and Tumor Immunology, Charité Universitätsmedizin, 13353 Berlin, Germany.
  • Fan Y; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Grosschedl R; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Chelala C; School of Biology, Georgia Institute of Technology, Atlanta, USA.
  • Fitzgibbon J; Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, USA.
Nat Genet ; 46(2): 176-181, 2014 Feb.
Article in En | MEDLINE | ID: mdl-24362818
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cell Transformation, Neoplastic / Lymphoma, Follicular / Disease Progression / Genomics Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2014 Type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cell Transformation, Neoplastic / Lymphoma, Follicular / Disease Progression / Genomics Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Nat Genet Journal subject: GENETICA MEDICA Year: 2014 Type: Article Affiliation country: United kingdom